Norton Rose Fulbright’s 2023 Annual Litigation Trends Survey indicates that environmental, social and governance (ESG) concerns are growing. 

While only 2% of respondents reported ESG-related litigation in 2022, more than one-quarter of respondents (28%) said their exposure in this area had deepened and 24% expect increased exposure in the coming year. Moreover, of those concerned with class actions in the year ahead, more than one in three said ESG-related class actions stand among their greatest concerns. 

Download the 2023 Annual Litigation Trends Survey for more details.



This issue

2023 Annual Litigation Trends Survey - Employment and labor

Publication

Employment and labor

Norton Rose Fulbright releases its 2023 Annual Litigation Trends Survey

November 26, 2024

2023 Annual Litigation Trends Survey | Cybersecurity, data protection and data privacy

Publication

Cybersecurity, data protection and data privacy

Norton Rose Fulbright releases its 2023 Annual Litigation Trends Survey

November 26, 2024

2023 Annual Litigation Trends Survey | Class actions

Publication

Class actions

Norton Rose Fulbright releases its 2023 Annual Litigation Trends Survey

November 26, 2024

2023 Annual Litigation Trends Survey | Regulation and investigations

Publication

Regulation and investigations

Norton Rose Fulbright releases its 2023 Annual Litigation Trends Survey

November 26, 2024

2023 Annual Litigation Trends Survey - Litigation Preparedness

Publication

Litigation preparedness

Norton Rose Fulbright releases its 2023 Annual Litigation Trends Survey

November 26, 2024

Contacts

Steven D. Jansma
Steven D. Jansma
Head of Litigation and Disputes, United States
Email
steven.jansma@nortonrosefulbright.com
T: +1 210 270 9366
Jay Dewald
Jay Dewald
Head of Healthcare Investigations, United States
Email
jay.dewald@nortonrosefulbright.com
T: +1 210 270 7180
Jamila S. Mensah
Jamila S. Mensah
Partner
Email
jamila.mensah@nortonrosefulbright.com
T: +1 713 651 5504
Christopher Pelham
Christopher Pelham
Head of Litigation and Disputes, Los Angeles
Email
christopher.pelham@nortonrosefulbright.com
T: +1 213 892 9221
Rachel Roosth
Rachel Roosth
Partner
Email
rachel.roosth@nortonrosefulbright.com
T: +1 713 651 3734
Sandeep Savla
Sandeep Savla
Co-Head of Regulatory, Investigations, Securities and Compliance, United States
Email
sandeep.savla@nortonrosefulbright.com
T: +1 212 318 3159
William L. Troutman
William L. Troutman
Partner
Email
william.troutman@nortonrosefulbright.com
T: +1 213 892 9208

Practice areas:

Industries:

Recent publications

biotech test tubes

Publication

Strategic asset search and evaluation in biopharma

Biotechnology companies are primarily built around platform technologies and focused on asset specific value creation.

United States | April 16, 2025

Life sciences and pharmaceuticals
Why SPACs offer a robust alternative to IPO market amidst looming global trade war

Publication

Why SPACs offer a robust alternative to IPO market amidst looming global trade war

President Trump’s recent tariffs appear to have direct implications for initial public offering (IPO) activity in what was forecasted to be a blockbuster year for such markets.

United States | April 15, 2025

Mergers and acquisitions
Landmark executive order: Restoring America’s maritime dominance

Publication

Landmark executive order: Restoring America’s maritime dominance

The White House released the executive order “Restoring America’s Maritime Dominance.”

United States | April 14, 2025

Ports and terminals
Site search

Subscribe and stay up to date with the latest legal news, information and events . . .

Subscribe now